Benedicte Jørgenrud1,2, Lars C Stene3, German Tapia3, Håkon Bøås3, Milaim Pepaj2, Jens P Berg4, Per M Thorsby2, Matej Orešič5,6, Tuulia Hyötyläinen5,6, Kjersti S Rønningen1. 1. Department of Pediatric Research, Institute of Clinical Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway. 2. Hormone Laboratory, Department of Medical Biochemistry, Institute of Clinical Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway. 3. Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway. 4. Division of Diagnostic and Intervention, Institute of Clinical Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway. 5. Systems Medicine Department, Steno Diabetes Centre, Gentofte, Denmark. 6. VTT Technical Research Centre of Finland, Espoo, Finland.
Abstract
AIMS: The aim of this study was to investigate the longitudinal plasma metabolic profiles in healthy infants and the potential association with breastfeeding duration and islet autoantibodies predictive of type 1 diabetes. METHOD: Up to four longitudinal plasma samples from age 3 months from case children who developed islet autoimmunity (n = 29) and autoantibody-negative control children (n = 29) with the HLA DR4-DQ8/DR3-DQ2 genotype were analyzed using two-dimensional gas chromatography coupled to a time-of-flight mass spectrometer for detection of small polar metabolites. RESULTS: Plasma metabolite levels were found to depend strongly on age, with fold changes varying up to 50% from age 3 to 24 months (p < 0.001 after correction for multiple testing). Tyrosine levels tended to be lower in case children, but this was not significant after correction for multiple testing. Ornithine levels were lower in case children compared with the controls at the time of seroconversion, but the difference was not statistically significant after correcting for multiple testing. Breastfeeding for at least 3 months as compared with shorter duration was associated with higher plasma levels of isoleucine, and lower levels of methionine and 3,4-dihydroxybutyric acid at 3 months of age. CONCLUSIONS: Plasma levels of several small, polar metabolites changed with age during early childhood, independent of later islet autoimmunity status and sex. Breastfeeding was associated with higher levels of branched-chain amino acids, and lower levels of methionine and 3,4-dihydroxybutyric acid.
AIMS: The aim of this study was to investigate the longitudinal plasma metabolic profiles in healthy infants and the potential association with breastfeeding duration and islet autoantibodies predictive of type 1 diabetes. METHOD: Up to four longitudinal plasma samples from age 3 months from case children who developed islet autoimmunity (n = 29) and autoantibody-negative control children (n = 29) with the HLA DR4-DQ8/DR3-DQ2 genotype were analyzed using two-dimensional gas chromatography coupled to a time-of-flight mass spectrometer for detection of small polar metabolites. RESULTS: Plasma metabolite levels were found to depend strongly on age, with fold changes varying up to 50% from age 3 to 24 months (p < 0.001 after correction for multiple testing). Tyrosine levels tended to be lower in case children, but this was not significant after correction for multiple testing. Ornithine levels were lower in case children compared with the controls at the time of seroconversion, but the difference was not statistically significant after correcting for multiple testing. Breastfeeding for at least 3 months as compared with shorter duration was associated with higher plasma levels of isoleucine, and lower levels of methionine and 3,4-dihydroxybutyric acid at 3 months of age. CONCLUSIONS: Plasma levels of several small, polar metabolites changed with age during early childhood, independent of later islet autoimmunity status and sex. Breastfeeding was associated with higher levels of branched-chain amino acids, and lower levels of methionine and 3,4-dihydroxybutyric acid.
Authors: Jesse A Davidson; Zachary Pfeifer; Benjamin Frank; Suhong Tong; Tracy T Urban; Paul A Wischmeyer; Peter Mourani; Bruce Landeck; Uwe Christians; Jelena Klawitter Journal: J Am Heart Assoc Date: 2018-12-18 Impact factor: 5.501
Authors: Santosh Lamichhane; Esko Kemppainen; Kajetan Trošt; Heli Siljander; Heikki Hyöty; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Tuulia Hyötyläinen; Mikael Knip; Matej Orešič Journal: Diabetologia Date: 2019-08-23 Impact factor: 10.122
Authors: Randi K Johnson; Lauren Vanderlinden; Brian C DeFelice; Katerina Kechris; Ulla Uusitalo; Oliver Fiehn; Marci Sontag; Tessa Crume; Andreas Beyerlein; Åke Lernmark; Jorma Toppari; Anette-G Ziegler; Jin-Xiong She; William Hagopian; Marian Rewers; Beena Akolkar; Jeffrey Krischer; Suvi M Virtanen; Jill M Norris Journal: Sci Rep Date: 2019-10-15 Impact factor: 4.379
Authors: German Tapia; Tommi Suvitaival; Linda Ahonen; Nicolai A Lund-Blix; Pål R Njølstad; Geir Joner; Torild Skrivarhaug; Cristina Legido-Quigley; Ketil Størdal; Lars C Stene Journal: J Clin Endocrinol Metab Date: 2021-09-27 Impact factor: 5.958